BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9413206)

  • 41. Angiomyolipoma of the liver in fine-needle aspiration biopsies: its distinction from hepatocellular carcinoma.
    Cha I; Cartwright D; Guis M; Miller TR; Ferrell LD
    Cancer; 1999 Feb; 87(1):25-30. PubMed ID: 10096356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Overexpression of heat shock protein 70 and spontaneous cancer cell apoptosis in hepatocellular carcinoma].
    Yin Y; Qin Q; Zhang W; Zhao J; Zhang C; Yu J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):84-5. PubMed ID: 11350684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The immunochemical demonstration of high-molecular proteins in the nuclear matrix of tumor cells].
    Filatova LS; Zbarskiĭ IB
    Biull Eksp Biol Med; 1993 Oct; 116(10):418-21. PubMed ID: 8117972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
    He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
    J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma.
    Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Harada T; Fujimoto M; Sakaida I; Okita K; Oka M; Nakamura K
    Proteomics; 2006 Jul; 6(13):3894-900. PubMed ID: 16767786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
    Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
    In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuclear and DNA-binding proteins in human brain tumors.
    Müller A; Henn W; Unteregger G
    Electrophoresis; 1991; 12(7-8):515-23. PubMed ID: 1915244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery.
    Lee YY; McKinney KQ; Ghosh S; Iannitti DA; Martinie JB; Caballes FR; Russo MW; Ahrens WA; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
    J Proteome Res; 2011 Nov; 10(11):5070-83. PubMed ID: 21913717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-dimensional electrophoretic analysis of nuclear proteins from human tumors.
    Menzel A; Unteregger G
    Electrophoresis; 1989; 10(8-9):554-62. PubMed ID: 2806204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of the Golgi proteome of hepatocellular carcinoma with that of the adjacent non-tumor tissues].
    Xiao Z; Yi YF; He TT; Li YQ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):23-6. PubMed ID: 20128964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of nuclear matrix proteins in serum from cancer patients.
    Miller TE; Beausang LA; Winchell LF; Lidgard GP
    Cancer Res; 1992 Jan; 52(2):422-7. PubMed ID: 1728414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered nuclear matrix protein profiles in oncogene-transformed mouse fibroblasts exhibiting high metastatic potential.
    Samuel SK; Minish TM; Davie JR
    Cancer Res; 1997 Jan; 57(1):147-51. PubMed ID: 8988056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear matrix protein alterations associated with colon cancer metastasis to the liver.
    Brünagel G; Schoen RE; Bauer AJ; Vietmeier BN; Getzenberg RH
    Clin Cancer Res; 2002 Oct; 8(10):3039-45. PubMed ID: 12374670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein patterns in various malignant human brain tumors by two-dimensional gel electrophoresis.
    Narayan RK; Heydorn WE; Creed GJ; Jacobowitz DM
    Cancer Res; 1986 Sep; 46(9):4685-94. PubMed ID: 3731119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Phosphorylation of the nuclear matrix proteins of the liver and of Zajdela's hepatoma in the rat].
    Mal'dov DG; Pham AK; Luchnik AN; Zbarskiĭ IB
    Biull Eksp Biol Med; 1984 Aug; 98(8):177-9. PubMed ID: 6466853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas.
    Zeindl-Eberhart E; Haraida S; Liebmann S; Jungblut PR; Lamer S; Mayer D; Jäger G; Chung S; Rabes HM
    Hepatology; 2004 Feb; 39(2):540-9. PubMed ID: 14768008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of a novel nuclear protein in normal and regenerating liver cells.
    Chew EC; Cheng-Chew SB; DeHarven E; Liew CC
    In Vivo; 1992; 6(1):97-102. PubMed ID: 1627750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fractionation and biosynthesis of rat liver and Zajdela hepatoma nuclear matrix proteins].
    Kuz'mina SN; Bul'diaeva TV; Zbaraskiĭ IB
    Biokhimiia; 1980 Aug; 45(8):1417-24. PubMed ID: 7236794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-dimensional gel electrophoresis of acid-extractable nuclear proteins of regenerating and thioacetamide-treated rat liver, Morris 9618a hepatoma, and Walker 256 carcinosarcoma.
    Yeoman LC; Taylor CW; Busch H
    Cancer Res; 1974 Feb; 34(2):424-8. PubMed ID: 4359383
    [No Abstract]   [Full Text] [Related]  

  • 60. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry.
    Seow TK; Ong SE; Liang RC; Ren EC; Chan L; Ou K; Chung MC
    Electrophoresis; 2000 May; 21(9):1787-813. PubMed ID: 10870966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.